Listing 1 - 9 of 9 |
Sort by
|
Choose an application
Choose an application
Background Since the heyday of HTA it has been claimed that ethics is an integral part of HTA. However, few HTA reports have addressed moral issues, and there has been little agreement on methods for implementing ethics in HTA. Therefore, there is a need to develop a standard methodology for addressing ethical issues in HTA in the same manner as there is a methodology for systematic reviews and economic analysis. Accordingly, the purpose of this report is to present a practical method for addressing moral issues in HTA. The method has to be applicable without special knowledge in ethics, and when applied, the method shall result in a broad basis for an open and transparent decision process. Accordingly, it shall only highlight the moral issues, and not lead to specific recommendations. Method On the basis of analyses and assessments of existing methods in ethics in general and in HTA in particular, a practical procedure for addressing moral issues in HTA is to be developed and presented. Results A practical method for addressing moral issues in HTA is presented. The method consists of a procedure in six steps:1. Identify and analyze the moral challenges with the health technology2. Identify involved persons, groups, and stakeholders3. Identify relevant moral questions (from a list of questions) and justify the selection4. Perform literature search in accordance with the identified moral questions5. Analyze and discuss the moral questions identified (in step 3) on the basis of1.1. The literature search1.2. Hearings of involved parties or qualitative studies6. Wrap up and summarize the process. The core set of moral questions in step 3 belong to the following main groups: 1. General moral issues. 2. Moral issues related to stakeholders 3. Moral issues related to the health technology. 4. Moral issues related to methodological choices in HTA. 5. Moral issues related to HTA itself. Addressing the moral issues shall result in a broad basis for an open and transparent decision process. Conclusion A practical procedure has been developed for ethical analysis in HTA, based on an analysis of existing methods. The procedure is based on six steps and a selection of 32 moral issues to be addressed.
Choose an application
Background About 300 women get cervical cancer and about 100 die from cervical cancer every year in Norway. Cervical cancer is primarily caused by continuous infection with human papilloma virus (HPV), and over 120 strains of HPV have been identified. About 14 of these are are oncogenic. HPV-16 and HPV-18 can be found in about 70% of of the women with cervical cancer. Most HPV infections will cease by themselves, but where the infections persist, there is an increased risk for cellular changes. There exist vaccines against HPV 16/18, but there is yet no evidence that the vaccine is effective against cervical cancer. This has incited fierce debates on whether to introduce the HPV vaccine in national or statewide vaccination programs. This report aims at highlighting and discussing the moral aspects that are relevant for the decision making process with regards to HPV vaccine. Method The report uses a method developed for addressing ethical issues in health technology assessments (HTAs) that discusses central moral questions related to health interventions. The aim is not to give unequivocal answers to the questions, but rather to elucidate arguments and aspects that are important for decision makers and stake holders. Results The potential utility of HPV-16/18 vaccination is considerable, but morally challenging, as the real impact of HPV vaccination on cervical cancer is not known, and the vaccine is costly. Vaccination is an intervention towards healthy people, calling for special attention, especially as there is considerable uncertainty about its effects and side effects. It is challenging to assess future utility of potential prophylactic interventions against the utility of health interventions today. HPV vaccine of children is also challenging with respect to informed consent. Informing the public and potential persons to receive the vaccine appears to be a considerable challenge. Conclusion HPV vaccination can potentially save 40 women from getting cervical cancer every year and 13 from dying, but there is no evidence for this, and vaccination is costly. That raises a series of morally challenging issues that are important to address when deciding whether to implement the vaccine or not (and how to implement it).
Choose an application
Background Since the heyday of HTA it has been claimed that ethics is an integral part of HTA. However, few HTA reports have addressed moral issues, and there has been little agreement on methods for implementing ethics in HTA. Therefore, there is a need to develop a standard methodology for addressing ethical issues in HTA in the same manner as there is a methodology for systematic reviews and economic analysis. Accordingly, the purpose of this report is to present a practical method for addressing moral issues in HTA. The method has to be applicable without special knowledge in ethics, and when applied, the method shall result in a broad basis for an open and transparent decision process. Accordingly, it shall only highlight the moral issues, and not lead to specific recommendations. Method On the basis of analyses and assessments of existing methods in ethics in general and in HTA in particular, a practical procedure for addressing moral issues in HTA is to be developed and presented. Results A practical method for addressing moral issues in HTA is presented. The method consists of a procedure in six steps:1. Identify and analyze the moral challenges with the health technology2. Identify involved persons, groups, and stakeholders3. Identify relevant moral questions (from a list of questions) and justify the selection4. Perform literature search in accordance with the identified moral questions5. Analyze and discuss the moral questions identified (in step 3) on the basis of1.1. The literature search1.2. Hearings of involved parties or qualitative studies6. Wrap up and summarize the process. The core set of moral questions in step 3 belong to the following main groups: 1. General moral issues. 2. Moral issues related to stakeholders 3. Moral issues related to the health technology. 4. Moral issues related to methodological choices in HTA. 5. Moral issues related to HTA itself. Addressing the moral issues shall result in a broad basis for an open and transparent decision process. Conclusion A practical procedure has been developed for ethical analysis in HTA, based on an analysis of existing methods. The procedure is based on six steps and a selection of 32 moral issues to be addressed.
Choose an application
Background About 300 women get cervical cancer and about 100 die from cervical cancer every year in Norway. Cervical cancer is primarily caused by continuous infection with human papilloma virus (HPV), and over 120 strains of HPV have been identified. About 14 of these are are oncogenic. HPV-16 and HPV-18 can be found in about 70% of of the women with cervical cancer. Most HPV infections will cease by themselves, but where the infections persist, there is an increased risk for cellular changes. There exist vaccines against HPV 16/18, but there is yet no evidence that the vaccine is effective against cervical cancer. This has incited fierce debates on whether to introduce the HPV vaccine in national or statewide vaccination programs. This report aims at highlighting and discussing the moral aspects that are relevant for the decision making process with regards to HPV vaccine. Method The report uses a method developed for addressing ethical issues in health technology assessments (HTAs) that discusses central moral questions related to health interventions. The aim is not to give unequivocal answers to the questions, but rather to elucidate arguments and aspects that are important for decision makers and stake holders. Results The potential utility of HPV-16/18 vaccination is considerable, but morally challenging, as the real impact of HPV vaccination on cervical cancer is not known, and the vaccine is costly. Vaccination is an intervention towards healthy people, calling for special attention, especially as there is considerable uncertainty about its effects and side effects. It is challenging to assess future utility of potential prophylactic interventions against the utility of health interventions today. HPV vaccine of children is also challenging with respect to informed consent. Informing the public and potential persons to receive the vaccine appears to be a considerable challenge. Conclusion HPV vaccination can potentially save 40 women from getting cervical cancer every year and 13 from dying, but there is no evidence for this, and vaccination is costly. That raises a series of morally challenging issues that are important to address when deciding whether to implement the vaccine or not (and how to implement it).
Choose an application
The Ethics of Research Biobanking investigates some of the ethical, legal and social challenges raised by research biobanking. In the first part of the book the authors pursue the different regulatory options envisaged within a normative terrain dictated by different conceptions and interpretations of the informed consent doctrine. In the second part a completely new approach is explored. The authors investigate the conceptual potential of different analogies outside medical research used to depict people's change and exchange of valuables between themselves and a common institution. The book is aimed at both academic and professional audiences (biobank curators, biobank researchers, ethicists, gene-epidemiologists, health law experts, philosophers, social scientists and advanced and graduate students in the relevant disciplines) as well as health and research regulators, ministries, politicians and the general public.
Professional ethics. Deontology --- Histology. Cytology --- Hygiene. Public health. Protection --- Epidemiology --- Human genetics --- medische genetica --- gezondheidszorg --- genetica --- deontologie --- epidemiologie --- cytologie --- histologie --- Bioethics --- Biobanks --- Biological resource centers --- Biological specimens --- Biological Specimen Banks --- Bioethical Issues --- Biomedical Research
Choose an application
This book offers the policy-maker or decision-maker key insights and practical information regarding the features of ethics frameworks best suited to the ethical assessment of human cognitive enhancement (HCE) applications, such as pharmaceutical cognitive enhancers and noninvasive brain stimulation techniques. This book takes as its departure point the entrenched philosophical debate between opponents and proponents of HCE and the increased feasibility of some applications of HCE. Recent calls for policy-making in the area of human enhancement reflect the need to find a balance between addressing current ethical issues and issues that are more speculative in nature or are underpinned by abstract philosophical concepts. Practical ethical approaches for policy or decision-making should enable the development of an evidence base for the risks and benefits of HCE applications. Moreover, such practical approaches should also incorporate a broader range of value bases that would facilitate convergence regarding certain decisions and judgements. This book identifies and evaluate tools that help us to go beyond polarised philosophical debates in order to assist practical decision makers in concrete ethical deliberation and decision-making. The focus is on systematic methods with which to identify relevant ethical values and assess the impacts of an HCE application on those values in order to facilitate decision-making regarding the ethical acceptability or desirability of the application. .
Philosophy. --- Neurosciences. --- Bioethics. --- Social sciences. --- Social Sciences, general. --- Intelligence tests. --- Cognition --- Testing --- Evaluation. --- Intelligence levels --- Intelligence testing --- IQ tests --- Mental tests --- Psychology --- Psychological tests --- Behavioral sciences --- Human sciences --- Sciences, Social --- Social science --- Social studies --- Civilization --- Neural sciences --- Neurological sciences --- Neuroscience --- Medical sciences --- Nervous system --- Biology --- Biomedical ethics --- Life sciences --- Life sciences ethics --- Science --- Moral and ethical aspects
Choose an application
This book offers the policy-maker or decision-maker key insights and practical information regarding the features of ethics frameworks best suited to the ethical assessment of human cognitive enhancement (HCE) applications, such as pharmaceutical cognitive enhancers and noninvasive brain stimulation techniques. This book takes as its departure point the entrenched philosophical debate between opponents and proponents of HCE and the increased feasibility of some applications of HCE. Recent calls for policy-making in the area of human enhancement reflect the need to find a balance between addressing current ethical issues and issues that are more speculative in nature or are underpinned by abstract philosophical concepts. Practical ethical approaches for policy or decision-making should enable the development of an evidence base for the risks and benefits of HCE applications. Moreover, such practical approaches should also incorporate a broader range of value bases that would facilitate convergence regarding certain decisions and judgements. This book identifies and evaluate tools that help us to go beyond polarised philosophical debates in order to assist practical decision makers in concrete ethical deliberation and decision-making. The focus is on systematic methods with which to identify relevant ethical values and assess the impacts of an HCE application on those values in order to facilitate decision-making regarding the ethical acceptability or desirability of the application. .
Professional ethics. Deontology --- Social sciences (general) --- Neuropathology --- neurologie --- sociale wetenschappen --- bio-ethiek --- medische ethiek
Choose an application
Listing 1 - 9 of 9 |
Sort by
|